CF
CRMD icon

Corebridge Financial’s CorMedix CRMD Stock Holding History

Corebridge Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-29,698
Closed -$183K – 658
2025
Q1 		$183K Sell
29,698
-440
-1% -$4.55K ﹤0.01% 2125
2024
Q4 		$244K Buy
30,138
+768
+3% +$7.67K ﹤0.01% 2063
2024
Q3 		$237K Sell
29,370
-181
-0.6% -$979 ﹤0.01% 2132
2024
Q2 		$128K Buy
+29,551
New +$150K ﹤0.01% 2456

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

Corebridge Financial's CRMD Position: Q2 2025 in Review

Corebridge Financial sold out of CorMedix (CRMD) in Q2 2025, closing a stake of 29,698 shares — an estimated $183K sold.

Corebridge Financial first reported a position in CRMD in Q2 2024 and held it in 4 quarters. The position peaked at $244K in Q4 2024. 172 funds tracked by Wall St. Rank hold CRMD as of Q2 2025.

  • Corebridge Financial reported no remaining CorMedix position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 29,698 CorMedix shares in Q2 2025, an estimated $183K.
  • Corebridge Financial first reported a position in CorMedix in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's CorMedix position peaked at $244K in Q4 2024.
  • 172 funds tracked by Wall St. Rank held CorMedix as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.